Academia Sinica and vaccine developer Moderna Inc. have agreed to jointly develop messenger ribonucleic acid (mRNA) technology and cultivate research talent in Taiwan under a five-year strategic partnership announced Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Seasonal wind, cold air mass to bring mercury down to 10°C by weekend
11/25/2024 11:31 PM - Sports
Taiwan baseballers return home after historic Premier12 title
11/25/2024 10:50 PM - Business
Industrial production rises for 8th straight month in October
11/25/2024 10:39 PM - Sports
Japan's SoftBank Hawks sign young Taiwanese pitcher
11/25/2024 10:34 PM - Society
Mongolian man to be deported after serving jail term for rape: Court
11/25/2024 10:22 PM